• Company
• Deregulate to foster new modalities like ADC, gene therapy
• by Son, Hyung Min Nov 29, 2024 05:55am

• Company
• Samsung Bioepis names Kyung-Ah Kim as new CEO
• by Nov 29, 2024 05:55am

• Company
• 'Global obesity drug market 79 times bigger than Korea'
• by Son, Hyung Min Nov 29, 2024 05:55am

• Policy
• Concerns about National Bio Committee's foreign pharma exec
• by Lee, Jeong-Hwan Nov 29, 2024 05:54am

• Company
• Sales rights for Viviant·Tuvero·Akarb to be transferred
• by Kim JiEun Nov 28, 2024 05:55am

• Policy
• KIPO opposes to objections to new drug patent extended cap
• by Lee, Jeong-Hwan Nov 28, 2024 05:55am

• Policy
• Trial for targeted drug 'VERT-002' for NSCLC begins in KOR
• by Lee, Hye-Kyung Nov 28, 2024 05:55am

• Policy
• Handok’s thrombocytopenia drug Doptelet approved in KOR
• by Lee, Hye-Kyung Nov 28, 2024 05:54am

• Policy
• Lagevrio prescription age raised from 60 to 70
• by Kang, Shin-Kook Nov 28, 2024 05:54am

• Company
• Lilly appoints Stacie Liu to head the CardioMetabolic Health
• by Eo, Yun-Ho Nov 28, 2024 05:54am